Protembis
Aachen, DE · Founded 2013 · 16 employees on LinkedIn · 7 known investors
Find your way into Protembis
Protembis is a German medical device company developing the ProtEmbo Cerebral Protection System, an intra-aortic filter device inserted via the left radial artery that shields the brain from embolic debris during transcatheter aortic valve replacement (TAVR) and other left-sided heart procedures. The device aims to reduce the risk of stroke and cognitive decline for cardiac patients and is undergoing clinical investigation.
Founders & leadership
Investors · 7
European Investment Bank✓ verifiedLuxembourg
TechVision FondsAachen · $500K – $2M
XGEN VentureMilan
coparionreported · 2 sourcesCologne · $540K – $8.6M
TechVision FundreportedAachen · $550K – $2.2M
Also in the syndicate · 2
Segulah Medical AccelerationleadThe European Investment Bank (EIB)
Funding
SEC filings, press & company announcements- Undisclosed amountSeries BMar 2024
Segulah Medical Acceleration (lead), TechVision Fund (lead), XGEN Venture (lead), Coparion
Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
In the news
Frequently asked questions
- What does Protembis do?
- Protembis is a German medical device company developing the ProtEmbo Cerebral Protection System, an intra-aortic filter device inserted via the left radial artery that shields the brain from embolic debris during transcatheter aortic valve replacement (TAVR) and other left-sided heart procedures. The device aims to reduce the risk of stroke and cognitive decline for cardiac patients and is undergoing clinical investigation.
- Who are Protembis's investors?
- Protembis's investors include European Investment Bank, TechVision Fonds, XGEN Venture, coparion, TechVision Fund.
- Where is Protembis headquartered?
- Protembis is headquartered in Aachen, DE.